Cubist Systematic Strategies’s Sagimet Biosciences SGMT Stock Holding History

Cubist Systematic Strategies’s Portfolio SGMT Stock Details SGMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$190K	Buy	+27,662	New	+$224K	﹤0.01%	2669

Other funds holding SGMT

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Cubist Systematic Strategies's SGMT Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Sagimet Biosciences (SGMT) in Q3 2025: 27,662 shares worth $190K. The stake represents ﹤0.01% of the portfolio and ranks #2669 among its holdings.

72 funds tracked by Wall St. Rank hold SGMT as of Q3 2025.

Cubist Systematic Strategies held 27,662 shares of Sagimet Biosciences worth $190K as of Q3 2025.
Sagimet Biosciences was a new Cubist Systematic Strategies position in Q3 2025.
Sagimet Biosciences made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2669 holding.
72 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.